ADVERTISEMENT

James Sheffield

P038 Ozanimod First-Dose Cardiac Effects in Patients with Moderately to Severely Active Ulcerative Colitis and Relapsing Multiple Sclerosis

BACKGROUND: Ozanimod, an oral sphingosine 1-phosphate (S1P) receptor modulator that selectively targets S1P 1 and S1P ...

Raymond Cross , MD;

Jonathan Calkwood ;

Millie D. Long , MD, MPH;

Ayanbola Elegbe ;

James Sheffield ;

AnnKatrin Petersen ;

Lorna Charles ;

Harris A. Ahmad ;

12/15/2021

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Advertisement

Advertisement

Advertisement

Upcoming Events

October 29 ⁠–⁠ November 2

November 1 ⁠–⁠ November 2

November 6 ⁠–⁠ November 8

NEI Congress

November 7 ⁠–⁠ November 10

November 8 ⁠–⁠ November 10

WoundCon

November 8

Dermatology Week

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

See Full Calendar

Advertisement

Advertisement